Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.40 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8063156 | 0.85 | ALDH1A1 (0.60) | SIGMAR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL15494468 | 0.85 | SIGMAR1 (0.50) | SIGMAR1KDM4EALOX15ALPLPTBP1 | |
| SCHEMBL18177907 | 0.84 | ALDH1A1 (0.63) | SIGMAR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL19958938 | 0.82 | SIGMAR1 (0.43) | SIGMAR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL8059039 | 0.81 | SMN1; SMN2 (0.66) | SIGMAR1KDM4EALOX15ALDH1A1MEN1 | |
| SCHEMBL24884865 | 0.81 | SIGMAR1 (0.50) | SIGMAR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL8434592 | 0.79 | SIGMAR1 (0.54) | SIGMAR1KDM4EALOX15ALPLPTBP1 | |
| SCHEMBL25570287 | 0.79 | HTT (0.55) | SIGMAR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL8248140 | 0.78 | ALDH1A1 (0.61) | SIGMAR1KDM4EALOX15ALPLPTBP1 | |
| SCHEMBL27259214 | 0.78 | SIGMAR1 (0.56) | SIGMAR1KDM4EALOX15ALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240230687-A1 | MASS TAGS FOR LIPID ANALYSES | TEXAS A & M UNIV SYS (US) | 2024-07-11 | — | — | US | disclosed |
| US-20080132500-A1 | Antibiotic compounds | MERCK SHARP & DOHME CORP. | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240230687-A1 | MASS TAGS FOR LIPID ANALYSES | MBOAT7, LIPC, PNLIP | SIGMAR1 4727/4885KDM4E 3120/4885ALOX15 497/4885 |
| US-20080132500-A1 | Antibiotic compounds | NRDC, MRPL21, PEPD | SIGMAR1 2910/4885KDM4E 4740/4885ALOX15 4220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.